238 related articles for article (PubMed ID: 15714686)
41. Next Generation Sequencing approach to molecular diagnosis of Duchenne muscular dystrophy; identification of a novel mutation.
Ebrahimzadeh-Vesal R; Teymoori A; Azimi-Nezhad M; Hosseini FS
Gene; 2018 Feb; 644():1-3. PubMed ID: 29246534
[TBL] [Abstract][Full Text] [Related]
42. Molecular diagnosis of Duchenne muscular dystrophy.
Nallamilli BR; Ankala A; Hegde M
Curr Protoc Hum Genet; 2014 Oct; 83():9.25.1-29. PubMed ID: 25271841
[TBL] [Abstract][Full Text] [Related]
43. DMD and West syndrome.
Cardas R; Iliescu C; Butoianu N; Seferian A; Gataullina S; Gargaun E; Nectoux J; Bienvenu T; Craiu D; Gidaro T; Servais L
Neuromuscul Disord; 2017 Oct; 27(10):911-913. PubMed ID: 28802771
[TBL] [Abstract][Full Text] [Related]
44. Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy.
Brinkmeyer-Langford C; Balog-Alvarez C; Cai JJ; Davis BW; Kornegay JN
BMC Genomics; 2016 Aug; 17(1):665. PubMed ID: 27549615
[TBL] [Abstract][Full Text] [Related]
45. James V. Neel. The William Allan Memorial Award.
Bearn AG
Am J Hum Genet; 1966 Jan; 18(1):1-2. PubMed ID: 5321889
[No Abstract] [Full Text] [Related]
46. The William Allan Memorial Award Address: Gene clusters, Genome organization, and complex phenotypes. When the sequence is known, what will it mean?
Bodmer WF
Am J Hum Genet; 1981 Sep; 33(5):664-82. PubMed ID: 6975040
[No Abstract] [Full Text] [Related]
47. Duchenne and Becker muscular dystrophy: from gene diagnosis to molecular therapy.
Matsuo M
IUBMB Life; 2002 Mar; 53(3):147-52. PubMed ID: 12102170
[TBL] [Abstract][Full Text] [Related]
48. 2002 William Allen Award address. Introductory speech for Albert de la Chapelle.
Rowley JD
Am J Hum Genet; 2003 Feb; 72(2):233-5. PubMed ID: 12635648
[No Abstract] [Full Text] [Related]
49. Development of CRISPR-Mediated Systems in the Study of Duchenne Muscular Dystrophy.
Cai A; Kong X
Hum Gene Ther Methods; 2019 Jun; 30(3):71-80. PubMed ID: 31062609
[TBL] [Abstract][Full Text] [Related]
50. Noncoding RNAs and Duchenne muscular dystrophy.
Perry MM; Muntoni F
Epigenomics; 2016 Nov; 8(11):1527-1537. PubMed ID: 27603567
[TBL] [Abstract][Full Text] [Related]
51. The natural history of the patients with Duchenne muscular dystrophy in Taiwan: A medical center experience.
Liang WC; Wang CH; Chou PC; Chen WZ; Jong YJ
Pediatr Neonatol; 2018 Apr; 59(2):176-183. PubMed ID: 28903883
[TBL] [Abstract][Full Text] [Related]
52. Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach.
Freund AA; Scola RH; Arndt RC; Lorenzoni PJ; Kay CK; Werneck LC
Arq Neuropsiquiatr; 2007 Mar; 65(1):73-6. PubMed ID: 17420831
[TBL] [Abstract][Full Text] [Related]
53. Duchenne muscular dystrophy caused by a novel deep intronic DMD mutation.
Ginsberg MR; McCarty AJ; Lacomis D; Abdel-Hamid HZ
Muscle Nerve; 2018 Jun; 57(6):E136-E138. PubMed ID: 29346715
[No Abstract] [Full Text] [Related]
54. Genetic analysis of 62 Chinese families with Duchenne muscular dystrophy and strategies of prenatal diagnosis in a single center.
Zhang J; Ma D; Liu G; Wang Y; Liu A; Li L; Luo C; Hu P; Xu Z
BMC Med Genet; 2019 Nov; 20(1):180. PubMed ID: 31727011
[TBL] [Abstract][Full Text] [Related]
55. Exon-skipping therapy for Duchenne muscular dystrophy.
Nakamura A; Takeda S
Neuropathology; 2009 Aug; 29(4):494-501. PubMed ID: 19486303
[TBL] [Abstract][Full Text] [Related]
56. Patients with Duchenne muscular dystrophy are significantly shorter than those with Becker muscular dystrophy, with the higher incidence of short stature in Dp71 mutated subgroup.
Matsumoto M; Awano H; Lee T; Takeshima Y; Matsuo M; Iijima K
Neuromuscul Disord; 2017 Nov; 27(11):1023-1028. PubMed ID: 28734761
[TBL] [Abstract][Full Text] [Related]
57. Jérôme Lejeune. The William Allan Memorial Award presented at the annual meeting of the American Society of Human Genetics, San Francisco, California, October 3, 1969.
Knudson AG
Am J Hum Genet; 1970 Mar; 22(2):119-20. PubMed ID: 4244916
[No Abstract] [Full Text] [Related]
58. Xp21/A translocation: a rarely considered genetic cause for manifesting carriers of duchenne muscular dystrophy.
Trippe H; Wieczorek S; Kötting J; Kress W; Schara U
Neuropediatrics; 2014 Oct; 45(5):333-5. PubMed ID: 25046452
[TBL] [Abstract][Full Text] [Related]
59. Duchenne muscular dystrophy: genome editing gives new hope for treatment.
Crispi V; Matsakas A
Postgrad Med J; 2018 May; 94(1111):296-304. PubMed ID: 29386334
[TBL] [Abstract][Full Text] [Related]
60. Novel human pathological mutations. Gene symbol: DMD. Disease: muscular dystrophy, Duchenne.
Garcia-Planells J; Torres-Puente M; Vilchez JJ; Pérez-Alonso M
Hum Genet; 2009 Aug; 126(2):338. PubMed ID: 19694016
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
